[1]
Streit M, Böhlen LM, Hunziker T, Zimmerli S, Tscharner GG, Nievergelt H, Bodmer T, Braathen LR. Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient. European journal of dermatology : EJD. 2006 Jan-Feb:16(1):79-83
[PubMed PMID: 16436349]
[2]
Ackleh AS, Delcambre ML, Sutton KL. A second-order high-resolution finite difference scheme for a size-structured model for the spread of Mycobacterium marinum. Journal of biological dynamics. 2015:9 Suppl 1():156-87. doi: 10.1080/17513758.2014.962998. Epub 2014 Oct 1
[PubMed PMID: 25271885]
[3]
Parent LJ, Salam MM, Appelbaum PC, Dossett JH. Disseminated Mycobacterium marinum infection and bacteremia in a child with severe combined immunodeficiency. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1995 Nov:21(5):1325-7
[PubMed PMID: 8589169]
[4]
Chen L, Liu Z, Su Y, Wang D, Yin B, Shu B, Zhang J, Zhu X, Jia C. Characterization of Mycobacterium marinum infections in zebrafish wounds and sinus tracts. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2017 May:25(3):536-540. doi: 10.1111/wrr.12540. Epub 2017 Jul 10
[PubMed PMID: 28466489]
[5]
Prouty MG, Correa NE, Barker LP, Jagadeeswaran P, Klose KE. Zebrafish-Mycobacterium marinum model for mycobacterial pathogenesis. FEMS microbiology letters. 2003 Aug 29:225(2):177-82
[PubMed PMID: 12951238]
Level 3 (low-level) evidence
[6]
Hashish E, Merwad A, Elgaml S, Amer A, Kamal H, Elsadek A, Marei A, Sitohy M. Mycobacterium marinum infection in fish and man: epidemiology, pathophysiology and management; a review. The veterinary quarterly. 2018 Dec:38(1):35-46. doi: 10.1080/01652176.2018.1447171. Epub
[PubMed PMID: 29493404]
[7]
Jernigan JA, Farr BM. Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection: case report and review of the literature. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2000 Aug:31(2):439-43
[PubMed PMID: 10987702]
Level 3 (low-level) evidence
[8]
Aubry A, Mougari F, Reibel F, Cambau E. Mycobacterium marinum. Microbiology spectrum. 2017 Apr:5(2):. doi: 10.1128/microbiolspec.TNMI7-0038-2016. Epub
[PubMed PMID: 28387180]
[9]
Seneviratne K, Herieka E. A rifampicin-resistant Mycobacterium marinum infection in a newly diagnosed HIV-1 individual. International journal of STD & AIDS. 2013 Jan:24(1):75-7. doi: 10.1258/ijsa.2012.012244. Epub 2013 May 6
[PubMed PMID: 23512514]
[10]
Canetti D, Riccardi N, Antonello RM, Nozza S, Sotgiu G. Mycobacterium marinum: A brief update for clinical purposes. European journal of internal medicine. 2022 Nov:105():15-19. doi: 10.1016/j.ejim.2022.07.013. Epub 2022 Jul 19
[PubMed PMID: 35864075]
[11]
Primm TP, Lucero CA, Falkinham JO 3rd. Health impacts of environmental mycobacteria. Clinical microbiology reviews. 2004 Jan:17(1):98-106
[PubMed PMID: 14726457]
[12]
Hosseini Fard SM, Yossefi MR, Esfandiari B, Sefidgar SA. Mycobacterium marinum as a cause of skin chronic granulomatous in the hand. Caspian journal of internal medicine. 2011 Winter:2(1):198-200
[PubMed PMID: 24024015]
[13]
Ang P, Rattana-Apiromyakij N, Goh CL. Retrospective study of Mycobacterium marinum skin infections. International journal of dermatology. 2000 May:39(5):343-7
[PubMed PMID: 10849123]
Level 2 (mid-level) evidence
[14]
Posteraro B, Sanguinetti M, Garcovich A, Ardito F, Zampetti A, Masucci L, Sbordoni G, Cerimele D, Fadda G. Polymerase chain reaction-reverse cross-blot hybridization assay in the diagnosis of sporotrichoid Mycobacterium marinum infection. The British journal of dermatology. 1998 Nov:139(5):872-6
[PubMed PMID: 9892957]
[15]
Rathish B, Mohammed SM, Ullal K, Hassan S, Wilson A. Tropical Aquatic Skin and Soft Tissue Infections: A Series of Three Cases. Cureus. 2021 Feb 6:13(2):e13170. doi: 10.7759/cureus.13170. Epub 2021 Feb 6
[PubMed PMID: 33692929]
Level 3 (low-level) evidence
[16]
López-Varela E, García-Basteiro AL, Santiago B, Wagner D, van Ingen J, Kampmann B. Non-tuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis. The Lancet. Respiratory medicine. 2015 Mar:3(3):244-56. doi: 10.1016/S2213-2600(15)00062-4. Epub 2015 Mar 9
[PubMed PMID: 25773213]
[17]
Winthrop KL, Yamashita S, Beekmann SE, Polgreen PM, Infectious Diseases Society of America Emerging Infections Network. Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Jun 1:46(11):1738-40. doi: 10.1086/587989. Epub
[PubMed PMID: 18419421]
Level 3 (low-level) evidence
[18]
Schliemann S, Rässler F, Tittelbach J, Kranzer K, Zollmann C, Elsner P. Disseminated Mycobacterium marinum skin infection due to chronic lymphedema in an immunocompetent patient. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2018 May:16(5):614-616. doi: 10.1111/ddg.13491. Epub 2018 Mar 30
[PubMed PMID: 29603601]
[19]
Tenbrick P, Beer M, Beer K. Treatment of biopsy and culture negative Mycobacterium marinum: diagnostic and therapeutic considerations. Journal of drugs in dermatology : JDD. 2014 Feb:13(2):204-6
[PubMed PMID: 24509973]
[20]
Bråbäck M, Riesbeck K, Forsgren A. Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones. Antimicrobial agents and chemotherapy. 2002 Apr:46(4):1114-6
[PubMed PMID: 11897601]
[21]
Bonnet E, Debat-Zoguereh D, Petit N, Ravaux I, Gallais H. Clarithromycin: a potent agent against infections due to Mycobacterium marinum. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1994 Apr:18(4):664-6
[PubMed PMID: 8038339]
[22]
Aubry A, Chosidow O, Caumes E, Robert J, Cambau E. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Archives of internal medicine. 2002 Aug 12-26:162(15):1746-52
[PubMed PMID: 12153378]
Level 3 (low-level) evidence
[23]
Chow SP, Ip FK, Lau JH, Collins RJ, Luk KD, So YC, Pun WK. Mycobacterium marinum infection of the hand and wrist. Results of conservative treatment in twenty-four cases. The Journal of bone and joint surgery. American volume. 1987 Oct:69(8):1161-8
[PubMed PMID: 3667646]
Level 3 (low-level) evidence